AlphaCentric Advisors LLC
- SEC CIK
- 0001913464
- Latest filing
- Jul 24, 2026
DSGN holding history
Design Therapeutics, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 21,537
- Value
- $311.6K
- % of portfolio
- 0.3%
- Quarters held
- 3
- Since Q4 2025